Analysts Come Out Bullish On Radius Health, Shares Rally
Early Wednesday morning, four analyst firms issued notes initiating bullish coverage on Radius Health (NASDAQ: RDUS).
Shares of Radius Health have shot up nearly six percent on the news. The firms respective ratings and price targets are listed below.
- Canaccord Genuity - Buy, $21
- Cowen & Company - Outperform, N/A
- Cantor Fitzgerald - Buy, $20
- Jefferies - Buy, $17
The average of these price targets is $19.33, which represents 53 percent upside to last check price of $12.62.
Latest Ratings for RDUS
|Nov 2014||Cantor Fitzgerald||Maintains||Buy|
|Oct 2014||Canaccord Genuity||Maintains||Buy|
|Sep 2014||Canaccord Genuity||Maintains||Buy|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.